Verition Fund Management
TMCI icon

Verition Fund Management’s Treace Medical Concepts TMCI Stock Holding History

Verition Fund Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,973
Closed -$53.8K – 3515
2025
Q4 		$53.8K Sell
21,973
-502
-2% -$2.18K ﹤0.01% 3376
2025
Q3 		$151K Hold
22,475
– – ﹤0.01% 3537
2025
Q2 		$132K Sell
22,475
-13,960
-38% -$90.9K ﹤0.01% 3448
2025
Q1 		$306K Sell
36,435
-34,298
-48% -$308K ﹤0.01% 2855
2024
Q4 		$526K Sell
70,733
-17,637
-20% -$118K ﹤0.01% 2453
2024
Q3 		$513K Buy
88,370
+8,468
+11% +$54.4K ﹤0.01% 2312
2024
Q2 		$531K Buy
79,902
+53,200
+199% +$430K ﹤0.01% 2022
2024
Q1 		$348K Buy
+26,702
New +$356K ﹤0.01% 2208

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Verition Fund Management's TMCI Position: Q1 2026 in Review

Verition Fund Management sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 21,973 shares — an estimated $53.8K sold.

Verition Fund Management first reported a position in TMCI in Q1 2024 and held it in 8 quarters. The position peaked at $531K in Q2 2024. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Verition Fund Management reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 21,973 Treace Medical Concepts shares in Q1 2026, an estimated $53.8K.
  • Verition Fund Management first reported a position in Treace Medical Concepts in Q1 2024 and held it in 8 quarters.
  • Verition Fund Management's Treace Medical Concepts position peaked at $531K in Q2 2024.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.